|1.||Fowler, Joseph F: 1 article (11/2015)|
|2.||Deleo, Vincent A: 1 article (11/2015)|
|3.||Lorenz, Douglas: 1 article (11/2015)|
|4.||Zirwas, Matthew J: 1 article (11/2015)|
|5.||Warshaw, Erin M: 1 article (11/2015)|
|6.||Fransway, Anthony F: 1 article (11/2015)|
|7.||Pratt, Melanie: 1 article (11/2015)|
|8.||Shaughnessy, Cristin N: 1 article (11/2015)|
|9.||Sasseville, Denis: 1 article (11/2015)|
|10.||Marks, James G: 1 article (11/2015)|
11/01/2008 - "Ultimately, a majority of patch testing studies have shown that clinical allergy to CAPB-containing products actually reflects allergy to contaminant DMAPA in most cases. "
04/01/2003 - "We consider that simultaneous allergic reaction to DMAPA and amidoamine represents cross-reactivity and hypothesize that DMAPA is in fact the true sensitizing substance, while amidoamine, which may in any case release DMAPA in vivo as a result of enzymatic hydrolysis, may favour the transepidermal penetration of the sensitizing agent. "
04/01/2003 - "To this end, in 10 patients with contact allergy to a commercial CAPB, we tested DMAPA 1% aq. "
07/01/1999 - "Only 1 of the subjects showed an allergic reaction to DMAPA. "
07/01/1999 - "10 individuals with a clinical history of contact allergy to CAPB (by positive patch test and history) took part in a ROAT which used a CAPB-based shower gel at 25% (DMAPA concentration < 1 ppm). "
|2.||Contact Dermatitis (Eczema, Contact)
11/01/2015 - "This study reports the frequency of positive patch test results to surfactants tested on the North American Contact Dermatitis Group screening series including cocamidopropyl betaine (CAPB), amidoamine (AA), dimethylaminopropylamine (DMAPA), oleamidopropyl dimethylamine (OPD), and cocamide diethanolamide (CDEA), and correlations of positive reactions between CAPB and the other surfactants. "
|3.||Allergic Contact Dermatitis
11/01/2008 - "DMAPA is an important etiology of allergic contact dermatitis of the eyelids and face but is easily missed even with expanded-series patch testing. "
04/01/2006 - "We present three cases of allergic contact dermatitis to DMAPA. "
01/01/2008 - "429 consecutive patients with suspected allergic contact dermatitis were patch tested with CAPB 1.0% aqueous, 3-dimethylaminopropylamine (DMAPA) 1.0% aqueous as well as a modified European standard series of allergens from June 2005 to August 2006. "
11/01/2008 - "When patch-testing for eyelid and facial dermatitis, it is crucial to test with DMAPA directly, not just with CAPB; unlike commercial-grade CAPB, the CAPB in patch test kits is ultrapure and does not contain contaminant DMAPA."
01/01/2008 - "Both CAPB and DMAPA should be tested in patients with suspected cosmetic dermatitis."
|2.||Surface-Active Agents (Surfactants)